 irrevers tubulointerstiti damag chronic aminonucleosid nephrosi amelior angiotensin enzym inhibit chronic nephrosi tubulointerstiti damag rout frequenc drug administr differ group injuri tubulointerstiti process revers resolut heavi proteinuria normal valu author singl jugular intraven administr puromycin aminonucleosid PA munich-wistar rat triphas pattern glomerular injuri proteinuria focal glomerulosclerosi week drug administr author later progress tubulointerstiti morpholog abnorm acut nephrosi phase spontan resolut glomerular injuri intermedi period phase II model treatment rat angiotensin enzym inhibitor enalapril mg/l drink water period magnitud proteinuria acut nephrot phase recurr proteinuria phase iii sever interstiti fibrosi extent tubular dilat number intratubular cast semiquantit score conclus studi addit enalapril-tr rat low-molecular-weight protein excret recurr phase proteinuria preserv tubular function capac protein vitro cytotox studi glomerular viscer epitheli cell sensit PA contrast rat tubular epithelium cellular control exact pathogenet mechan respons develop tubulointerstiti damag unknown PA vitro affect rat tubular epithelium clear correl magnitud recurr proteinuria sever tubulointerstiti morpholog abnorm benefici effect enzym inhibit untoward process